The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age
- PMID: 29921174
- DOI: 10.1089/thy.2017.0607
The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age
Abstract
Background: Although the importance of tumor size in papillary thyroid cancer (PTC) is well established, there is no research investigating whether age modifies the impact of tumor size, and there is conflicting evidence regarding optimal size thresholds for prognostic discrimination. We aimed to verify that tumor size is an independent prognostic factor in PTC, investigate the impact of patient age, and identify optimal size cutoffs for risk stratification using objective measures of model performance.
Methods: A retrospective analysis of 574 patients with PTC, using multivariate Cox regression models to test the impact of tumor size on recurrence-free survival (RFS). Subgroup analyses were performed in patients aged <55 and ≥55 years. Exploratory analyses to identify optimal size cutoffs for prognostic discrimination were performed using the proportion of variation explained (PVE) and Harrell's C-index.
Results: Tumor size predicted RFS on multivariate analysis in the overall study cohort (hazard ratio [HR] 1.16; [95% confidence interval (CI)1.01-1.34]; p = 0.038). In subgroup analysis, there was no association between tumor size and RFS in patients aged <55 years (HR 1.11; [CI 0.89-1.38]; p = 0.362). In contrast, size was an independent predictor of RFS in patients aged ≥55 years (HR 1.52; [CI 1.11-2.07]; p = 0.009). In this subgroup, an optimal size threshold of >2 cm versus ≤2 cm (HR 5.24; [CI 2.30-11.92]; p < 0.001; PVE: 36%; C-index: 0.66) provided the greatest prognostic discrimination. There was no incremental improvement in prognostic value by further stratification of size.
Conclusion: In our PTC cohort, the impact of tumor size on RFS was limited to patients aged ≥55 years. A single size threshold of 2 cm maximized prognostic discrimination with tumors >2 cm associated with a five times higher risk of recurrence than those ≤2 cm. These findings need to be validated in independent large cohorts and the potential management and staging implications further studied.
Keywords: age; papillary carcinoma; thyroid cancer; thyroid neoplasm; tumor size.
Similar articles
-
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.J Clin Endocrinol Metab. 2017 Sep 1;102(9):3241-3250. doi: 10.1210/jc.2017-00277. J Clin Endocrinol Metab. 2017. PMID: 28582521 Free PMC article.
-
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29. Head Neck. 2015. PMID: 24821456
-
Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.Thyroid. 2015 Feb;25(2):216-20. doi: 10.1089/thy.2014.0075. Epub 2014 Nov 19. Thyroid. 2015. PMID: 25322334
-
The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.Thyroid. 2012 Nov;22(11):1144-52. doi: 10.1089/thy.2012.0043. Epub 2012 Oct 19. Thyroid. 2012. PMID: 23083442 Review.
-
Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma.Endocr J. 2014;61(3):205-13. doi: 10.1507/endocrj.ej13-0403. Epub 2013 Dec 9. Endocr J. 2014. PMID: 24212880 Review.
Cited by
-
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.Front Endocrinol (Lausanne). 2023 Mar 13;14:1128963. doi: 10.3389/fendo.2023.1128963. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36992807 Free PMC article.
-
Development and validation of nomograms to predict early death for elderly lung cancer patients.Front Surg. 2023 Feb 13;10:1113863. doi: 10.3389/fsurg.2023.1113863. eCollection 2023. Front Surg. 2023. PMID: 36860947 Free PMC article.
-
Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.Front Endocrinol (Lausanne). 2022 Oct 24;13:1008301. doi: 10.3389/fendo.2022.1008301. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36353231 Free PMC article.
-
Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-Up.World J Surg. 2023 May;47(5):1211-1218. doi: 10.1007/s00268-022-06813-5. Epub 2022 Oct 27. World J Surg. 2023. PMID: 36303039 Free PMC article.
-
A predictive model for early death in elderly patients with gastric cancer: A population-based study.Front Oncol. 2022 Aug 22;12:972639. doi: 10.3389/fonc.2022.972639. eCollection 2022. Front Oncol. 2022. PMID: 36072801 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
